Gaudium IVF And Women Health Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 18/03/2026 ,inter alia, to consider and approve unaudited standalone ....
GAUDIUMIVF · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Gaudium IVF and Women Health Ltd has informed BSE that its Board of Directors will meet on Wednesday, March 18, 2026. The Board will consider and approve the Unaudited Standalone and Consolidated Financial Results for the quarter and nine months ended December 31, 2025. It will also take on record the Limited Review Report of the Auditor for the period. The trading window for insiders is already closed since the company's listing date of February 27, 2026, and will reopen 48 hours after the results are declared. This is a recently listed company (Scrip Code 544709).
No direct impact on stock price from this intimation alone, but the upcoming Q3 results will be the first set of financial numbers disclosed as a listed company, which could set the tone for near-term investor sentiment.